New research outlines a critical driver in an immune cell's defense against melanoma

Researchers have found critical new insights into how cells defend against melanoma. The team describes how an enzyme called nicotinamide phosphoribosyltransferase, or NAMPT, initiates antitumor activity. The researchers suggest that new therapies strengthening this pathway in immune cells could be the foundation for more effective treatments against melanoma.

from Top Health News -- ScienceDaily https://ift.tt/3uN3ERe